论文部分内容阅读
目的探究与分析三九胃泰颗粒与奥美拉唑联合应用治疗功能性消化不良的临床疗效及安全性。方法选取我院自2011年12月至2013年12月收治的功能性消化不良患者者60例,将其作为临床研究对象,采取随机数字表法分为对照组与试验组,每组各30例。对照组仅给予奥美拉唑治疗,试验组在其基础上加用三九胃泰颗粒。观察与比较两组患者经不同治疗方式下的临床效果。结果试验组患者达总有效人数明显多于对照组,P<0.05,具有统计学意义。结论采用三九胃泰颗粒联合奥美拉唑治疗功能性消化不良的临床效果显著,值得进一步研究并推广。
Objective To investigate and analyze the clinical efficacy and safety of Sanjiuweitai granule combined with omeprazole in the treatment of functional dyspepsia. Methods Sixty patients with functional dyspepsia admitted in our hospital from December 2011 to December 2013 were selected and divided into control group and experimental group by random number table . The control group was given omeprazole only, and the experimental group added Sanjiuweitai granule on the basis of the above. The clinical effects of two groups of patients under different treatment were observed and compared. Results The total effective number of patients in the experimental group was significantly more than the control group, P <0.05, with statistical significance. Conclusion The clinical effect of Sanjiuweitai granule combined with omeprazole in treating functional dyspepsia is significant and worthy of further study and promotion.